Database

Startups

Main Industry
Biotechnology
Main Product/Service
1. AC-203
2. AC-1101
3. AC-203
Founded Year
2010
Unified Business No.
25147136
Status
Active
Number of Employees
0
Total Paid-in Capital
2,055,793,950 (NT$)
Location of Company
Taiwan , Taipei City
Exit Status
Emerging Stock Exchange(2016)
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself. Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
About the Company
Ancheng Biotechnology Co., Ltd. (hereinafter referred to as Ancheng Biotech) is a new drug research and development company headquartered in Taipei, Taiwan, which develops and treats rare diseases. The strategy is to re-position the drug molecules already in clinical use. There is no need for good medicine or emerging medicines, especially for rarediseases that are severely and drug-free. They aim to be efficient and innovative, providing safe and effective new drugs to patients in need around the world.



more ↓

Similar Companies

EVERFRONT BIOTECH INC.

1. EF-001 (Cerebraca® Wafer)
2. EF-009 Wafer
3. HK-001
4. EF-031
5. TSCA-001
6. EF-011

ANYA BIOPHARM INC.

ORAL PEPTIDE
Summary of development timelines-product
MIRA/JE® Design
Lead Optimization
Preclinical Studies
Phase I
Phase II
Phase III
ANY002 Oral GLP1 product A: Prototype with human PK results available
ANY004 Oral GLP1 product B: Prototype in animal st
:::
回頁面最頂端